distribution agreement

Sysmex anticipates delivering the kit to Japanese medical institutions this month for diagnosis of the SARS-CoV-2 infection.

The point-of-care test is designed for the qualitative presumptive detection of specific IgM and IgG antibodies to SARS-CoV-2 in a fingerstick blood sample.

The rapid one-step Anti-SARS-CoV-2 Rapid Test detects IgG and IgM antibodies to SARS-CoV-2 and was developed by Autobio.

The deal took effect immediately and shipments have to Spain, France, Germany, and the UK have begun.

The testing products, developed by China-based 3D Medicines, have received CE marking and approval from the Chinese National Medical Products Administration, Todos said.

PreCheck Health has an initial order of 30,000 tests and will register the product in Ecuador. The two firms have a similar distribution agreement covering Russia.

The immunoassay designed for the rapid, qualitative, and differential detection of SARS-CoV-2 IgG and IgM antibodies in blood, serum, or plasma.

AdGeniX started distributing Yourgene's Iona test in France in 2015 and has rapidly grown sales for the test, a trend that is expected to continue.

Both deals involve the Inspirata's steps to expand partnerships for its digital pathology solution, the Dynamyx case management platform.  

The Shenzhen Mammoth Public Welfare Foundation, which BGI sponsors, has also raised funding to purchase PCR and automate sample preparation instruments.